Sun. November 23, 2008
-
MarketWatch
November 20, 2008
... Geron Corporation and Exeter Life Sciences Establish stART Licensing, Inc II-44 Cambrex Establishes New Facility to Manufacture Cell Therapy II-44 6. ...
VentureBeat
October 30, 2008
... in $15 million in a second round of funding led by Exeter Life Sciences and including BASF Venture Capital America, CMEA Ventures and Saints Capital. ...
Cleantech Group
October 29, 2008
The new round came from existing investors Exeter Life Sciences, CMEA Ventures, BASF Venture Capital America and Saints Capital. ...
Bizjournals.com
October 29, 2008
The investment was led by Exeter Life Sciences. Other participants included CMEA Ventures, BASF Venture Capital America Inc. and Saints Capital. ...
MarketWatch
October 28, 2008
The transaction was led by Exeter Life Sciences, with full participation of other key shareholders including CMEA Ventures, BASF Venture Capital America ...
Biotech Transfer Week
August 13, 2008
Geron and Exeter Life Sciences said this week that Start Licensing, a joint venture between the two firms, and ViaGen, a subsidiary of Exeter, ...
Bizjournals.com
August 12, 2008
Geron Corp. and Exeter Life Sciences Inc. on Tuesday announced a combined company, Start Licensing Inc., which will manage and license a portfolio of ...
Market Wire (press release)
June 24, 2008
... Geron Corporation and Exeter Life Sciences Establish stART Licensing, Inc II-44 Cambrex Establishes New Facility to Manufacture Cell Therapy II-44 6. ...
Scientific American
June 20, 2008
... Inc., a company formed in 2005 by Geron Corporation and
Exeter Life Sciences, Inc. to manage both
companies' intellectual property rights, including the ...
TMCnet
April 16, 2008
Geron Corp., of Menlo Park, Calif., received a $1.5 million milestone payment from Exeter Life Sciences Inc., of Phoenix, triggered by the final risk ...
SmallCapInvestor
April 16, 2008
... said this morning that received a milestone payment of $1.5 million from
Exeter Life Sciences, Inc. for the final "risk assessment" released by
the US ...
WELT ONLINE
February 17, 2008
About Start Licensing Start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a broad ...
CNNMoney.com
January 16, 2008
Created in 2005, Start is a joint venture of Geron Corporation and Exeter Life Sciences, Inc. Start manages and licenses a worldwide portfolio of ...
Earthtimes
December 11, 2007
Start is a joint venture of Geron Corporation and Exeter Life Sciences, Inc. Start manages and licenses a broad portfolio of intellectual property rights ...
